Article

    August 20, 2026

    Ramboll’s commitment to scientific integrity and transparency

    In complex environmental and human health matters, building and maintaining trust depends on the consistent application of transparent, objective science. This article explains how Ramboll ensures its scientific integrity, manages potential conflicts of interest and communicates evidence-based findings to support informed decision making.

    Industry

    #

    Regulations

    people in a park setting by a lake

    Share

    Share

    Contact our expert

    Eric S. Wood

    Eric S. Wood

    E&H Global Director for PFAS/Emerging Contaminants

    Our history and the foundation of our work

    For more than 40 years, Ramboll has applied a data-driven, science-based approach to addressing the most challenging environmental and human health issues facing our clients around the world. Over this time, we have earned a reputation for technical excellence and for upholding the highest professional standards of objectivity and integrity, as evidenced by our continued work for a broad array of clients including governmental agencies, scientific organisations and private sector companies.

    Our multidisciplinary staff includes environmental scientists and engineers, public health and safety specialists, economists, statisticians, and regulatory experts, who provide a wide range of consulting and engineering services. Much of our work for both public and private sector clients involves estimating and effectively communicating the potential human health and environmental risks associated with chemical contamination, identifying options for safe, cost-effective risk reduction, and, where appropriate, implementing remedial actions. We also assist private sector clients in understanding and managing their potential environmental liabilities, maintaining compliance with regulatory requirements, and achieving their sustainability goals.


    Both private and public sector clients rely on our expertise

    By working with a variety of clients in both public and private sectors, Ramboll is able to better understand the broad spectrum of technical perspectives that may exist on key issues. We provide our clients with clearly communicated and transparent findings and opinions based on objective analysis of the best science.

    Ramboll advocates for relying on the best science in regulatory decision-making. Our work can help regulatory agencies make informed decisions based on their own analysis and balancing of relevant criteria.

    In addition to our work for public and private sector clients, Ramboll staff are often asked to participate on expert panels convened by scientific organisations and regulatory agencies. Examples include:

    • US Environmental Protection Agency (EPA)
    • USEPA Science Advisory Committee on Chemicals (SACC)
    • The National Research Council (NRC) Board on Environmental Studies and Toxicology
    • The US Army Environmental Center
    • The American Society of Testing Materials (ASTM)
    • The National Institute of Environmental Health Sciences (NIEHS) Superfund Basic Research Program
    • American Board of Toxicology (ABT)
    • The United States Congress
    • UK REACH Independent Scientific Expert Pool (RISEP)
    • UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment (COT)
    • UK Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment (COC)


    Managing conflicts of interest

    Ramboll retains its independence and strives to avoid perceived conflicts of interest for all clients and on all projects by making certain that our conclusions and opinions are based on objective and transparent evaluation of scientific evidence from reliable sources.

    Ramboll also follows an internal new project review process for all proposed client engagements, to ensure that we avoid actual or perceived conflicts of interest and comply with any existing contract restrictions. Where appropriate or required, we will establish ethical walls to protect against disclosure of client information or communications that may be considered confidential in nature.        

    Public procurement processes are designed to uphold transparency, fairness and integrity. Ramboll diligently follows these procedures to ensure that any potential conflicts of interest are identified and cleared before engaging in consulting or engineering work for public agencies and regulatory bodies.


    Our emphasis on transparency and thought leadership

    Transparency is a cornerstone of Ramboll's work. We apply rigorous methodologies to ensure our analyses are clear and reliable, citing the sources of data, models and approaches we use to develop our conclusions and recommendations. Our experts regularly publish their work to allow for review by the scientific community and contribute to progress in resolving important environmental and human health issues. Examples include:

    • Ramboll colleagues were among the authors of the paper that received the Best Paper of the Year Award by the Society of Toxicology in 2024: Range of the perfluorooctanoate (PFOA) safe dose for human health: An international collaboration (2023), Regulatory Toxicology and Pharmacology 2023 Dec; 145: 105502.
    • Ramboll colleagues were among the authors of the paper that received the 2023 Arthur C. Stern Distinguished Paper Award from the Journal of the Air & Waste Management Association (JA&WMA): Recommendations on statistics and benchmarks to assess photochemical model performance, published in the May 2017 issue of Journal of Air and Waste Management.
    • High-resolution atmospheric modeling of fluorotelomer alcohols and perfluorocarboxylic acids in the North American troposphere, Environmental Science & Technology, volume 41, Issue 16
    • Atmospheric and watershed modelling of trifluoroacetic acid from oxidation of HFO-1234ze€ released by prospective pressurized metered-dose inhaler use in three major river basins, Atmos. Chem. Phys., 25, 15469–15486, 2025
    • Systematic review and meta-analysis of epidemiologic data on vaccine response in relation to exposure to five principal perfluoroalkyl substances, Environment International, Volume 172, February 2023
    • Extended analysis and evidence integration of chloroprene as a human carcinogen, Risk Analysis, 2020 Feb;40(2):294-318

    Contact our expert

    Eric S. Wood

    E&H Global Director for PFAS/Emerging Contaminants

    Contributing authors

    Explore similar insights

    Industry

    Regulations

    • Ramboll Foundation
    • Henning Larsen

    Bright ideas. 

    Sustainable change.

    ramboll logo
    • © 2026

    • Terms of use and Privacy Policy
    • Disclosures & Notices for California Residents
    • Whistleblower